100% French Stocks – Thursday, August 14, 2025

CAC 40 PREOPEN: 7,808 points (0.00%)

Key stocks of the day

Sanofi (SAN): Rilzabrutinib receives orphan drug designation in the EU for the treatment of IgG4-related disease. A positive catalyst for the R&D division.

Scor (SCR): The arbitration schedule with Covéa is maintained, with a final decision expected in 2026.

Carmat (ALCAR): Trading suspended from this morning, before a decisive hearing on a potential resumption scheduled for August 19. High risks for shareholders.

2CRSi (2CRSI): Signs a major €47M contract with Malaysia for AI servers – delivery expected by the end of 2025.

Intrasense (ALINS): Obtains CE marking for DUOnco Pancreas, an innovative solution in medical imaging.

Innelec Multimédia (ALINN): Q1 revenue up 2%, with strong growth in derivative product sales (+47%).

Analyst recommendations (French companies only)

Upward

Air Liquide (AI) → TD Cowen remains at buy, target raised from €200 to €205.
BNP Paribas (BNP) → RBC Capital maintains its outperform rating, target raised from €86 to €95.
Orange (ORA) → JP Morgan remains at overweight, target raised from €16.30 to €16.60.

Neutral

Klépierre (LI) → Goldman Sachs maintains its neutral rating, target raised from €31.30 to €32.30.

Downward

Spie (SPIE) → Morgan Stanley lowers its recommendation from overweight to market weight, despite a target increase from €47.50 to €52.50.

Have a good session everyone!
Sylvain Mouilhaud: Equity coach.